NasdaqHealth CareHealth Care FacilitiesS&P MidCap 400
$181.08
-1.31 (-0.72%)
Close of Nov 06, 2026 · end-of-day data
ENSG 8-K filings in 2024
Every material Form 8-K Ensign filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
The Ensign Group reported third-quarter 2024 GAAP diluted earnings per share of $1.34, up 20.7% from a year earlier, and adjusted diluted EPS of $1.39, up 15.8%. Revenue rose 15.0% to $1.08 billion, and the company raised its full-year 2024 EPS and revenue guidance, which matters to shareholders because it signals higher expected earnings and sales for the year.
Q3 2024 GAAP net income was $78.4 million, up 22.8% from the prior year quarter; GAAP diluted EPS was $1.34 versus $1.11.
Full-year 2024 diluted EPS guidance was raised to $5.46 to $5.52 from $5.38 to $5.50.
Full-year 2024 revenue guidance was raised to $4.25 billion to $4.26 billion from $4.20 billion to $4.22 billion.
Same Facilities occupancy rose 2.8% year over year to 81.7%; cash on hand was $532.1 million as of September 30, 2024.
The Ensign Group appointed Mark Parkinson, the former President and CEO of AHCA/NCAL, as a director, filling a seat created when shareholders expanded the board to nine members in May 2024. The Board determined he is independent, and he will serve until the 2025 Annual Meeting. The filing does not report financial results, so the change is a governance update rather than a change in company performance.
Mark Parkinson appointed to the Board effective October 21, 2024, after being appointed by the Board on October 17, 2024
Parkinson, age 67, served as AHCA/NCAL President and CEO for 14 years, from 2011 to 2024
Board expanded from eight to nine members by shareholder vote in May 2024; Parkinson determined to be independent
Expected to be nominated for a two-year Class II director term ending at the 2027 annual meeting
Ensign Group reported second-quarter 2024 GAAP diluted EPS of $1.22, up 8.9% from the prior year quarter, and total revenue of $1.04 billion, up 12.5%. The company raised its full-year 2024 earnings guidance to $5.38 to $5.50 per diluted share and its revenue guidance to $4.20 billion to $4.22 billion, which is favorable for shareholders.
Q2 2024 GAAP net income was $71.0 million, up 11.0%; adjusted EPS was $1.32, up 13.8%.
Full-year 2024 EPS guidance raised to $5.38 to $5.50 per diluted share, from $5.29 to $5.47.
Full-year 2024 revenue guidance raised to $4.20 billion to $4.22 billion, from $4.13 billion to $4.17 billion.
Ensign Group reported first-quarter 2024 GAAP diluted earnings per share of $1.19, up 13.3% from the prior year quarter, and adjusted diluted EPS of $1.30, up 15.0%. Revenue was $1.01 billion, up 13.9%, and the company affirmed its 2024 guidance of $5.29 to $5.47 per diluted share, which shareholders can use to compare against future results.
GAAP net income was $68.8 million, up 15.0% from the prior year quarter; adjusted net income was $75.4 million, up 16.6%
Total revenue was $1.01 billion for the quarter ended March 31, 2024, up 13.9% year over year
2024 guidance affirmed: diluted EPS of $5.29 to $5.47 and revenue of $4.13 billion to $4.17 billion
Cash and cash equivalents were $511.8 million at March 31, 2024, with $593.7 million of available line-of-credit capacity
Ensign Group reported fourth-quarter and full-year 2023 results, with revenue up 23.3% for the year and adjusted diluted EPS up 15.2%. GAAP diluted EPS fell from the prior year because of litigation costs outside the ordinary course of business, and the company issued 2024 guidance calling for diluted EPS of $5.29 to $5.47 and revenue of $4.13 billion to $4.17 billion.
Full-year 2023 total revenue was $3.73 billion, up 23.3%; fourth-quarter revenue was $980.4 million, up 21.1%.
Full-year GAAP diluted EPS was $3.65 versus $3.95 in 2022; adjusted diluted EPS was $4.77, up 15.2%.
Fourth-quarter GAAP diluted EPS was $0.38 versus $1.06, including $58.8 million of litigation costs that the company excludes from adjusted results.
2024 guidance: diluted EPS of $5.29 to $5.47 and revenue of $4.13 billion to $4.17 billion.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Ensign filing is on SEC EDGAR ↗. 8-K briefs of other companies →